Thus, this study was designed to screen and unveil the key targets and pathways of Cpn in alleviating obesity in mice by utilizing an integrated strategy that combined network pharmacology, quantitative transcriptomics, molecular docking, and experimental validation. The gene discussed is CPN1; the disease is obesity disorder.